PARADIGM ASSET MANAGEMENT CO LLC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 153 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 3.14 and the average weighting 0.2%.

Quarter-by-quarter ownership
PARADIGM ASSET MANAGEMENT CO LLC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2017$58,528,000
-45.5%
3,100
-50.8%
0.01%
-40.0%
Q1 2017$107,478,000
-95.4%
6,300
-96.7%
0.02%
-92.2%
Q2 2015$2,321,550,000
-24.6%
192,5000.0%0.26%
-24.6%
Q1 2015$3,080,000,000
+5.5%
192,500
+1.0%
0.34%
-9.5%
Q4 2014$2,918,460,000
+24.6%
190,500
+5.4%
0.38%
+15.2%
Q3 2014$2,342,264,000180,8000.33%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$157,835,70021.26%
AlphaCentric Advisors LLC 292,500$2,816,7751.60%
Quantedge Capital Pte Ltd 179,900$1,732,4370.94%
Intrinsic Value Partners, LLC 50,355$484,9190.62%
Brown Capital Management 3,719,796$35,821,6350.55%
ARMISTICE CAPITAL, LLC 3,456,000$33,281,2800.51%
SummerHaven Investment Management, LLC 67,765$652,5770.48%
BRAIDWELL LP 1,348,099$12,982,1930.41%
AFFINITY INVESTMENT ADVISORS, LLC 50,733$488,5590.32%
EMC Capital Management 43,315$4170.31%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders